Brighton Jones’s PTC Therapeutics PTCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-3,148
Closed -$257K – 1498
2026
Q2
$257K Buy
+3,148
New +$227K ﹤0.01% 1131
2025
Q3
– Sell
-4,628
Closed -$226K – 1053
2025
Q2
$226K Buy
+4,628
New +$220K 0.01% 832

Other funds holding PTCT

Brighton Jones's PTCT Position: Q3 2026 in Review

Brighton Jones sold out of PTC Therapeutics (PTCT) in Q3 2026, closing a stake of 3,148 shares — an estimated $257K sold.

Brighton Jones first reported a position in PTCT in Q2 2025 and held it in 2 quarters. The position peaked at $257K in Q2 2026. 302 funds tracked by Wall St. Rank hold PTCT as of Q3 2026.

  • Brighton Jones reported no remaining PTC Therapeutics position as of Q3 2026 after selling out during the quarter.
  • Brighton Jones sold 3,148 PTC Therapeutics shares in Q3 2026, an estimated $257K.
  • Brighton Jones first reported a position in PTC Therapeutics in Q2 2025 and held it in 2 quarters.
  • Brighton Jones's PTC Therapeutics position peaked at $257K in Q2 2026.
  • 302 funds tracked by Wall St. Rank held PTC Therapeutics as of Q3 2026.

Based on Brighton Jones's 13F filing for Q3 2026, filed 3 Nov 2026.